Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMAD3 | P84022 | 1/20 | 0.44 |
| ▸ | GNG2 | P59768 | 1/20 | 0.37 |
| ▸ | GNB1 | P62873 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.35 |
| ▸ | TYMS | P04818 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8207884 | 0.81 | SMAD3 (0.48) | SMAD3GNG2GNB1ALDH1A1DHFR | |
| SCHEMBL701249 | 0.81 | SMAD3 (0.44) | SMAD3GNG2GNB1ALDH1A1DHFR | |
| SCHEMBL10774632 | 0.80 | HPGD (0.51) | SMAD3ALDH1A1HPGDTDP1MEN1 | |
| SCHEMBL17001191 | 0.75 | SMAD3 (0.45) | SMAD3GNG2GNB1ALDH1A1HPGD | |
| SCHEMBL4478640 | 0.75 | SMAD3 (0.42) | SMAD3GNG2GNB1ALDH1A1TDP1 | |
| SCHEMBL1682554 | 0.75 | SMAD3 (0.40) | SMAD3GNG2GNB1ALDH1A1HPGD | |
| SCHEMBL3418230 | 0.73 | HPGD (0.45) | SMAD3ALDH1A1HPGDTDP1MEN1 | |
| SCHEMBL154596 | 0.72 | MEN1 (0.40) | SMAD3GNG2GNB1ALDH1A1HPGD | |
| SCHEMBL20526344 | 0.71 | SMAD3 (0.41) | SMAD3GNG2GNB1ALDH1A1DHFR | |
| SCHEMBL29401708 | 0.71 | GNG2 (0.50) | SMAD3GNG2GNB1ALDH1A1DHFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4340701-A1 | BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION | Belite Bio, LLC (US) | 2024-03-27 | — | — | EP | disclosed |
| EP-4337932-A1 | SYSTEMS FOR DETECTING LIGHT BY BIREFRINGENT FOURIER TRANSFORM INTERFEROMETRY AND METHODS FOR USING SAME | Becton, Dickinson and Company (US) | 2024-03-20 | — | — | EP | disclosed |
| WO-2024028486-A1 | IN VITRO METHOD FOR OBTAINING CLINICAL-GRADE CD8+ CD45RCLOW/- REGULATORY T CELLS | NANTES UNIVERSITE (FR) | 2024-02-08 | — | — | WO | disclosed |
| EP-4291901-A1 | USE OF MARKERS FOUND ON LYMPH NODE METASTATIC SAMPLES FOR THE PROGNOSIS OF BREAST CANCER | Universität Zürich (CH) | 2023-12-20 | — | — | EP | disclosed |
| WO-2023239730-A1 | SYSTEMS FOR RECONSTITUTING DRIED REAGENT COMPOSITIONS AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023219758-A1 | SYSTEMS FOR VACUUM MEDIATED LIPOSOME PREPARATION, AND METHODS FOR USING THE SAME | BECTON, DICKINSON AND COMPANY (US) | 2023-11-16 | — | — | WO | disclosed |
| WO-2023129460-A2 | TUMOR MHC CLASS I EXPRESSION IS ASSOCIATED WITH INTERLEUKIN-2 RESPONSE IN MELANOMA | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-07-06 | — | — | WO | disclosed |
| US-20230125113-A1 | MEASUREMENT OF PROTEIN EXPRESSION USING REAGENTS WITH BARCODED OLIGONUCLEOTIDE SEQUENCES | CELLULAR RESEARCH, INC. | 2023-04-27 | — | — | US | disclosed |
| US-20220042884-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2022-02-10 | — | — | US | disclosed |
| EP-3918090-A1 | OLIGONUCLEOTIDE-COMPRISING CELLULAR COMPONENT-BINDING REAGENTS AND METHODS OF USING THE SAME | Becton, Dickinson and Company (US) | 2021-12-08 | — | — | EP | disclosed |
| EP-1108060-A1 | MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE $i(M. TUBERCULOSIS) COMPLEX | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2001-06-20 | — | — | EP | disclosed |
| EP-0912597-A4 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | INTERGEN COMPANY (US) | 2001-04-11 | — | — | EP | disclosed |
| WO-2001006013-A1 | METHODS FOR DETERMINING THE SPECIFICITY AND SENSITIVITY OF OLIGONUCLEOTIDES FOR HYBRIDIZATION | ROSETTA INPHARMATICS, INC. (US) | 2001-01-25 | — | — | WO | disclosed |
| EP-1056765-A1 | HUMAN POTASSIUM CHANNEL GENES | Icagen, Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| US-6130073-A | DETECTING A TARGET NUCLEOTIDE SEQUENCES IN A SAMPLE; AMPLIFYING TARGET NUCLEOTIDE SEQUENCES BY PRIMER EXTENSION, LIGATING OLIGONUCLEOTIDE PROBES AND DETECTING LIGATION PRODUCTS | PERKIN-ELMER CORP., APPLIED BIOSYSTEMS DIVISION (US) | 2000-10-10 | — | — | US | disclosed |
| WO-2000011214-A1 | MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE M. TUBERCULOSIS COMPLEX | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-03-02 | — | — | WO | disclosed |
| WO-2000003037-A1 | SCREENING ARRAYS OF NUCLEOTIDES TO DETERMINE CORRESPONDENCE WITH BOTH SEQUENCE AND PHYSICAL PROPERTIES OF A PROBE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-01-20 | — | — | WO | disclosed |
| WO-1999043696-A1 | HUMAN POTASSIUM CHANNEL GENES | ICAGEN INC. (US) | 1999-09-02 | — | — | WO | disclosed |
| EP-0912597-A1 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | ONCOR, INC. (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998002449-A1 | NUCLEIC ACID AMPLIFICATION OLIGONUCLEOTIDES WITH MOLECULAR ENERGY TRANSFER LABELS AND METHODS BASED THEREON | ONCOR, INC. (US) | 1998-01-22 | — | — | WO | disclosed |